{"disease":{"id":"minimal-change-nephrotic-syndrome-mcns","name":"minimal change nephrotic syndrome mcns"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03970577","title":"RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":148,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT01763580","title":"A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Astellas Pharma Korea, Inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}